QuVa Pharma, Inc. has recalled 4,075 cassettes of compounded epidural medications, including Fentanyl Citrate with Bupivacaine or Ropivacaine. These products are being recalled due to a lack of assurance of sterility, which means the medication may not be completely free of microorganisms. The recalled items were distributed nationwide in the United States for institutional and office use.
Administration of a drug intended for epidural use that lacks sterility assurance poses a serious risk of infection, including meningitis or other life-threatening complications. No injuries or infections have been reported to date.
Recall #: D-0295-2025. For Institutional or Office Use Only.
Recall #: D-0296-2025. Quantity: 2,310 cassettes.
Recall #: D-0297-2025. Quantity: 1,765 cassettes.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.